Data on potential risks of COVID-19 in psoriasis patients limited, but reassuringOctober 23, 2020Psoriatic Arthritis
Non-Whites remain sorely underrepresented in phase 3 psoriasis trialsOctober 20, 2020Psoriatic Arthritis
Guselkumab improvements for psoriatic arthritis persist through 1 yearOctober 15, 2020Psoriatic Arthritis
Study highlights differences between White and Latino patients with psoriasisOctober 6, 2020Psoriatic Arthritis
Shingrix effective in older adults with preexisting immune-mediated disordersOctober 5, 2020Psoriatic Arthritis
Golimumab approval extended to polyarticular-course JIA and juvenile PsAOctober 2, 2020Psoriatic Arthritis
